KELSEY HARRIS: Open Payments
NPI 1619503117 · GREAT BEND, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 50 payments from 21 companies in 2025. Trend: 2023 $153 · 2024 $533 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $169 |
| PFIZER INC. | 11 | $147 |
| Radius Health, Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| CSL Behring | 2 | $55 |
| ABIOMED | 2 | $54 |
| Novo Nordisk Inc | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 3 | $43 |
| Pharming Healthcare, Inc. | 2 | $41 |
| BioCryst US Sales Co., LLC | 2 | $40 |
Products named: TAKHZYRO, NURTEC ODT, Tymlos, OCTAGAM IMMUNE GLOBULIN (HUMAN), CUVITRU, Andembry, REXULTI, RUCONEST.
Industry payments across KS — which companies pay providers there.
